EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands

Vikas R Aswar, Dnyandev B Jarhad, Jiyoon Song, Jinha Yu iD, Lak Shin Jeong iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Vikas R Aswar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. Hauptthemen laut MEDLINE: Receptor, Adenosine A3, Drug Design, Thionucleosides, Adenosine A3 Receptor Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine receptors (ARs) play crucial roles in various physiological processes, making them significant targets for therapeutic intervention. This study focuses on the design, synthesis, and evaluation of N 6‐substituted‐ C 2‐alkynyl‐4′‐thioadenosine and truncated 4′‐thioadenosine derivatives as selective ligands for the human A 3 adenosine receptor (hA 3 AR). Binding affinity assays demonstrated that modifications at the C 2‐alkyne and N 6‐amine positions significantly influenced receptor selectivity and potency. Compound 3b showed high affinity for hA 3 AR ( K i = 1.8 nM) with excellent subtype selectivity and acted as an agonist. In contrast, truncated derivative 6b was an antagonist, while 6s , which shares the same sugar structure as 6b , functioned as a partial agonist, highlighting the roles of sugar and base moieties in ligand function. Molecular docking studies provided further insight into distinct binding modes, demonstrating the impact of minor structural variations on ligand‐receptor binding dynamics. These findings contribute to the development of potent and selective A 3 AR modulators by emphasizing the importance of fine structural adjustments in ligand design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Adenosine A3Drug DesignThionucleosidesAdenosine A3 Receptor AgonistsAdenosine A3 Receptor AntagonistsHumansLigandsStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureDose-Response Relationship, DrugAlkynes

Stichwörter der Autor:innen

4′‐thionucleosideadenosine receptoragonistantagoniststructure‐activity relationship

Substanzen

Receptor, Adenosine A3LigandsThionucleosidesAdenosine A3 Receptor AgonistsAdenosine A3 Receptor AntagonistsAlkynes

Autor:innen und Institutionen

  • Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
  • College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.

ORCID-Profile: Jinha Yu, Lak Shin Jeong

Förderung

  • National Research Foundation of Korea
  • Korea Health Industry Development Institute

Zitieren

APA

Aswar, V. R., Jarhad, D. B., Song, J., Yu, J., & Jeong, L. S. (2025). Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands. ChemMedChem. https://doi.org/10.1002/cmdc.202500135

Vancouver

Aswar VR, Jarhad DB, Song J, Yu J, Jeong LS. Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands. ChemMedChem. 2025. doi:10.1002/cmdc.202500135

BibTeX
@article{Aswar2025,
  author = {Aswar, Vikas R and Jarhad, Dnyandev B and Song, Jiyoon and Yu, Jinha and Jeong, Lak Shin},
  title = {Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500135}
}
Kostenlos starten →